STOCK TITAN

Cutera Inc - CUTR STOCK NEWS

Welcome to our dedicated news page for Cutera (Ticker: CUTR), a resource for investors and traders seeking the latest updates and insights on Cutera.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cutera's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cutera's position in the market.

Rhea-AI Summary
Cutera, Inc. (CUTR) launches xeo+, a cutting-edge laser and light-based multi-application platform, improving treatment times, ease of use, and patient experience. The platform offers updated features and redesigned handpieces for faster treatments and enhanced comfort. xeo+ builds on the success of xeo, introducing new technology to meet evolving industry demands.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.29%
Tags
none
-
Rhea-AI Summary
Cutera, Inc. reported financial results for Q4 and full-year 2023 with revenue exceeding guidance, cash and securities ahead of expectations, and completion of a corporate restructuring program. Despite revenue declines, the company remains focused on operational excellence and global expansion of AviClear franchise.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-30.43%
Tags
-
Rhea-AI Summary
Cutera, Inc. (Nasdaq: CUTR) announces the delay in filing Quarterly Reports due to an inventory shortfall, affecting the release of financial results for the fourth quarter and full year 2023. The Company plans to file its reports by March 21, 2024, and hold a conference call for investors and analysts to discuss the matter.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.59%
Tags
Rhea-AI Summary
Cutera, Inc. (CUTR) announced the international limited commercial release of AviClear, the first energy-based device FDA-cleared for the long-term treatment of acne. The device, available in select practices in the United Kingdom, Europe, and Australia, uses a 1726nm laser to target and suppress sebum production. The pivotal clinical trial showed a 92% response rate and a 79% median reduction in inflammatory lesions at the 12-month mark. AviClear has received positive feedback from dermatologists and has been recognized by major beauty publications and awarded Cosmopolitan's 2023 Acne Award as Best Pro Treatment for Active Acne.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.02%
Tags
none
-
Rhea-AI Summary
Cutera, Inc. (Nasdaq: CUTR) announces unaudited financial results for the year ended December 31, 2023, with revenue expected in the range of $211.5 million to $212.5 million, surpassing prior guidance, and cash and marketable securities of approximately $143 million as of the end of the fourth quarter. CEO Taylor Harris highlighted operational improvements and corporate restructuring, setting the stage for a broader product launch in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
34.65%
Tags
-
Rhea-AI Summary
Cutera, Inc. (Nasdaq: CUTR) announced that their new Chief Legal Officer, Stephana Patton, will receive inducement awards in the form of stock options, restricted stock units, and performance stock units. These awards are subject to vesting conditions based on Ms. Patton's continued employment and the achievement of specific share price targets. The awards are granted in accordance with the Cutera, Inc. 2023 Inducement Equity Incentive Plan and Nasdaq Listing Rule 5635(c)(4).
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.28%
Tags
none
Rhea-AI Summary
Cutera, Inc. (Nasdaq: CUTR) received a notice from Nasdaq indicating non-compliance with listing rules due to the inability to file its Form 10-Q for the period ended September 30, 2023. The notice has no immediate effect on the listing or trading of the Company’s securities. Cutera has 60 days to submit a plan to regain compliance, with a possible extension of up to 180 days. However, there is no assurance that Nasdaq will accept the plan, and the Company is working diligently to complete the Form 10-Q.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.28%
Tags
none
-
Rhea-AI Summary
Cutera, Inc. (Nasdaq: CUTR) announces the appointment of Stephana Patton, Ph.D., J.D. as Chief Legal Officer, effective November 13, 2023. Dr. Patton will lead legal, compliance, intellectual property, and human resources functions, bringing over two decades of legal experience in the life sciences industry. The appointment reflects Cutera's commitment to operational excellence, customer support, and growth of the AviClear franchise.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.57%
Tags
management
-
Rhea-AI Summary
CUTR - Cutera, Inc. Announces Participation in Upcoming Investor Conferences. Cutera, a leader in aesthetic and dermatology solutions, will have its CEO and VP of Corporate FP&A and Investor Relations participate in fireside chats at three investor conferences. The webcasts will be accessible from the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
Rhea-AI Summary
Cutera, Inc. (Nasdaq: CUTR) provided preliminary financial results for Q3 2023, including a 26% revenue decrease, and recent business updates. The company announced an enhanced AviClear offering and initiated a global restructuring program expected to save over $20 million in personnel-related expenses.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-42.55%
Tags
Cutera Inc

Nasdaq:CUTR

CUTR Rankings

CUTR Stock Data

44.11M
16.52M
4.86%
91.15%
38.82%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Brisbane

About CUTR

cutera was established in the san francisco bay area (brisbane) in 1998 by veteran laser and optical engineers. as the pioneer of nd:yag technology, cutera® is the trusted authority in face + body energy-based medical aesthetic technologies that practitioners around-the-world turn to for innovation, sophistication and performance. at cutera, we’re always looking forward; developing new solutions, products and industry-leading services designed around the needs of medical aesthetic community—delivering better results, faster and safer than ever before. cutera’s premium portfolio of products include: xeo®, trusculpt® and excel v™. in 2014, cutera introduced two new exciting additions to their family of premium products: excel hr™ for high-speed, comfortable, hair removal and enlighten™, the industry’s first picosecond + nanosecond + 2 wavelength high-powered laser system. today, our worldwide presence is represented in 40 countries, with direct operations in north america, france, austra